Delivery Order SPE2DB22D1106-SPE2DB24FEJX0
Award Date 4/4/24
Potential Completion Date 4/5/24
Potential Value $3.5K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the supply of EXFORGE 10-320 MG TABLET 30S pharmaceutical products, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,854.04 Firm Fixed Price Delivery Order contract has a period of performance through May 31, 2023. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,668.33 firm fixed-price delivery order is for the supply of EXFORGE 10-320 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of January 30, 2025 and was awarded on January 29, 2025. This award is part of AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with the...
- This federal contract award is for the delivery of EXFORGE 10-320 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $5,433.51, was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the large pharmaceutical distribution company Amerisourcebergen Corporation. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is April 17, 2024. Amerisourcebergen Drug Corp holds a...
- This federal contract award is for the supply of EXFORGE 10-320 MG TABLET 30S to the Defense Logistics Agency (DLA), a defense agency. The $6,946.64 firm fixed-price delivery order was awarded on May 27, 2025 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a performance period through May 28, 2025. The contract is not set-aside. Amerisourcebergen Drug Corp is a critical vendor supporting federal medical procurement needs, particularly for military and veteran...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,193.43 to AmerisourceBergen Drug Corp, a subsidiary of the for-profit company AmerisourceBergen Corporation, to supply EXFORGE HCT 5-160-12.5 MG TAB 30S, a pharmaceutical product. This delivery order contract has a completion date of February 1, 2024 and was awarded on January 31, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide EXFORGE HCT 10-160-25 MG TAB 30S. This $1,225.14 award has a completion date of February 23, 2024. Amerisourcebergen Drug Corp is the prime contractor and this order is part of a larger indefinite delivery contract (IDC) it holds with DLA, potentially valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply EXFORGE 10-160 mg tablets. The $2,665.30 firm fixed price contract has an ultimate completion date of October 28, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide EXFORGE 10-320 MG TABLET 30S. The contract has a potential value of $1,763.88 and a performance period through January 31, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is issued under a larger indefinite delivery contract (IDC) that the company holds with DLA. The IDC has a...
- This federal contract award is a delivery order issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of EXFORGE 10-320 MG TABLET 30S, a medication, with a ceiling value of $1,070.31 and a completion date of June 27, 2025. The contract is a firm fixed-price arrangement, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the...
- This federal contract award is a firm fixed price delivery order worth $3,255.22 granted by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a for-profit subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of EXFORGE 5-160 MG TABLET 30S, a pharmaceutical product, with a completion date of February 12, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and...